ERBB2 amplifications across sex, race, and cancer types studied to guide HER2 therapies
Pre-emptive surgey to remove breasts and ovaries to prevent breast cancer in high risk BRCA1 and BRCA2 gene carrying patients; many factors to take into account in making the decision. MRI scans for high risk groups, chemoprevention and oophorectomy to prevent breast cancer.
ERBB2 amplifications across sex, race, and cancer types studied to guide HER2 therapies
Genomic testing: Awareness and effective communication between healthcare professionals and patients
Community-based breast cancer control programme in the Philipines
Initiatives for cancer control in Indonesia
PHERGain trial ID's early breast cancer cases that benefit from dual HER2 blockade without chemo
Navigating evidence-based care with limited resources in Africa
Genetic profiling identifies patients who can omit radiation therapy after breast-conserving surgery
Assessment of cervical and breast cancer screening in Latin America and Caribbean: CanScreen5/CELAC project
Long-term breast cancer risk after benign breast disease in population-based screening